ArticleJournal of gastroenterology2018

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer.

Takeru Wakatsuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.